To the Editor:

The sequencing of the human genome and the increasing availability of high-throughput genotyping have led to an upsurge in published genetic associations.1 Identifying true genetic associations among the large volume of false positives has always been a difficult task.2 The use of systematic reviews, particularly meta-analyses, has been recommended to summarize and assess the cumulative evidence on genetic associations.3 Even in the era of genome-wide association studies (GWAS), meta-analysis has a role in synthesizing and integrating results of genetic association studies,4 yet it is not clear if these efforts have kept pace.

Using two applications included in the recently deployed Human Genome Epidemiology (HuGE) Navigator,5 HuGE Watch and HuGEpedia, we found that meta-analyses increased threefold as a proportion of all published articles on genetic associations from 2001 to 2007 (Table 1); however, meta-analyses still represent only a tiny fraction (3%) of the genetic association literature. Among the 10 most frequently studied diseases (Table 2), genetic associations (e.g., APOE and Alzheimer disease) described in 25 or more primary research articles were far more likely to show at least one meta-analysis in the HuGEpedia (range, 47–100%) than those described in 10 to 24 articles (range, 9–69%) or in 5 to 9 articles (range, 0–32%).

Table 1 Articles reporting genetic associations, including meta-analyses, by year—HuGE Navigator knowledge base
Table 2 Genetic associations and meta-analyses for the 10 most commonly studied diseases—HuGE Navigator knowledge base

The increasing popularity of GWAS reinforces, rather than diminishes, the importance of knowledge synthesis, including meta-analysis.4 In GWAS, identifying true-positive associations with genetic variants among hundreds of thousands tested is further complicated by the multistage designs used by many GWAS to test for replication of statistically significant results.6 Meta-analyses may be useful for integrating results across stages to identify true associations and could be used as prior knowledge in Bayesian approaches of selecting variants to carry forward to subsequent stages of analysis.7 Furthermore, as with candidate gene studies, meta-analyses of GWAS can be used to calculate more precise measures of effect and assess the heterogeneity and generalizability of genetic associations.4,8

HuGENet, a global collaboration of researchers dedicated to advancing public health genomics, has collaborated with 11 journals to promote the conduct of systematic reviews, including meta-analysis (HuGE Reviews).3 Through December 2007, 65 HuGE reviews have been published. Topics are registered with HuGENet and displayed on the HuGE Web site to help prevent duplicate efforts and encourage collaboration between the researchers. Guidance for conducting HuGE Reviews is provided in the HuGENet HuGE Review Handbook (http://www.genesens.net/_intranet/doc_nouvelles/HuGE%20Review%20Handbook%20v11.pdf). Authors are also encouraged to use recently published interim guidelines to assess the cumulative evidence for the genetic association of interest.9 Authors interested in selecting a topic for a HuGE Review can use the HuGE Navigator, as we did, to identify gaps in knowledge synthesis.

Describing and confirming genetic associations is a crucial first step in realizing the potential of genomic medicine. We show that although research on genetic associations is booming, more attention needs to be devoted to efforts to synthesize and interpret research findings. Meta-analyses are most likely to focus on frequently studied genetic associations; however, we did not find meta-analyses in the HuGE Navigator for many associations that have been studied 10 or more times. Assessing the cumulative evidence for associations is important in a field so plagued by nonreplication.2 We encourage investigators to perform and publish systematic reviews and meta-analyses of genetic associations and for journals to publish this work as part of the ongoing translation of gene discoveries into clinical medicine and public health.